TAYLOR LEE: Open Payments
NPI 1184381956 · WYOMISSING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$254 in 5 payments from 3 companies in 2025. Trend: 2023 $80 · 2024 $26 · 2025 $254
Food & beverage: $254
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 1 | $150 |
| Lilly USA, LLC | 3 | $64 |
| Gilead Sciences, Inc. | 1 | $40 |
Products named: REZDIFFRA, ZEPBOUND, MOUNJARO.
Industry payments across PA — which companies pay providers there.
